Results 131 to 140 of about 7,937 (220)

Transthyretin amyloid cardiomyopathy: from cause to novel treatments. [PDF]

Eur Heart J
Fontana M, Aimo A, Emdin M, Porcari A, Solomon SD, Hawkins PN, Gillmore JD.   +6 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy : evolution in 2020

, 2020
La cardiopathie amyloïde à transthyréthine n’est plus considérée comme une pathologie rare dans sa forme sénile. Le traitement par Tafamidis a démontré une amélioration clinique et fonctionnelle des patients. Nous avons recueilli de manière rétrospective, les données cliniques, biologiques et échocardographiques des patients sous TAFAMIDIS inclus dans ...
openaire   +1 more source

Usefulness of Regional Longitudinal Strain to Identify Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Rep
Usuku H, Yamamoto E, Imamura K, Higashi R, Nozuhara A, Oike F, Kuyama N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Arima Y, Oda S, Kawano H, Matsuzawa Y, Izumiya Y, Ueda M, Tanaka Y, Tsujita K.   +18 more
europepmc   +1 more source

Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM. [PDF]

Future Cardiol
Sarswat N, Ambardekar AV, Alexander KM, Cuddy SA, Stern L, Poulsen SH, Tschöpe C, Sekijima Y, Sheikh FH, Griffin JM, Judge DP, Gillmore J, Masri A.   +12 more
europepmc   +1 more source

Population diversity of the genetically determined expression in human tissues and its implications in TTR amyloidosis [PDF]

core   +1 more source

Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia [PDF]

, 2015

core   +1 more source

Concomitant Transthyretin Amyloid Cardiomyopathy in Patients With Multiple Myeloma. [PDF]

JACC Case Rep
Ibrahim M, Alhusain R, Ray JC, Lyle MA, Leoni Moreno JC, Aslam N, Nativi Nicolau JN, Lin G, Sher T, Malik A.   +9 more
europepmc   +1 more source

Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Heart Fail
Lu R, Nalbandian A, Akita K, Teruya S, Bampatsias D, Santos AM, Maurer MS, Shimada YJ.   +7 more
europepmc   +1 more source

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis [PDF]

, 2015
Ackermann, Elizabeth J, Benson, Merrill D, Monia, Brett P   +2 more
core   +1 more source

Living with Transthyretin amyloid cardiomyopathy from a patient perspective. [PDF]

BMC Cardiovasc Disord
Bui QM, McCain J, Allen LA, Adler ED, Anderson C, Bloss C, Rabin BA, Urey MA.   +7 more
europepmc   +1 more source